The SGLT2 inhibitor, empagliflozin reduces early progressive proteinuria in obese SS rats
Sign Up to like & getrecommendations! Published in 2023 at "Physiology"
DOI: 10.1152/physiol.2023.38.s1.5733738
Abstract: Childhood/prepubertal obesity (PPO) is a world-wide epidemic and is considered a risk factor for renal injury. Therefore, there is a need to control this trend to decrease the future risk of chronic kidney disease. Recently,… read more here.
Keywords: empagliflozin; day; rats day; physiology ... See more keywords